Status:

COMPLETED

N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure

Lead Sponsor:

University of Pittsburgh

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Acute Liver Failure

Hepatic Encephalopathy

Eligibility:

All Genders

Up to 18 years

Phase:

PHASE3

Brief Summary

We have completed patient enrollment in the the double blind, randomized, placebo-controlled trial of intravenous (IV) N-acetylcysteine (NAC) vs. placebo for the treatment of non-acetaminophen ALF. Th...

Detailed Description

The Pediatric Acute Liver Failure (PALF) Study Group to identify, characterize, and develop management strategies for infants, children and adolescents who present with acute liver failure. The PALF s...

Eligibility Criteria

Inclusion

  • Meet entry criteria for and be enrolled in the Pediatric Acute Liver Failure prospective database.
  • Able to be evaluated and initiate treatment within the first 24 hours of hospitalization
  • Patients transferred from referring hospitals to the study site may be considered for enrollment, provided that no other treatment protocol has begun, and that no liver support device (BAL, extracorporeal liver assist device, transgenic pig perfusion) has been used or is contemplated.
  • Use of fresh frozen plasma infusions will not disqualify patients from participation.

Exclusion

  • older than 18 years of age
  • pregnancy
  • ALF that is secondary to acute acetaminophen toxicity, mushroom poisoning, or a known malignancy.
  • Patients who exhibit signs of cerebral herniation, have intractable arterial hypotension, require inotropic drugs, or demonstrate signs of sepsis (temperature ≥ 39.5o C or bacteremia) at the time of enrollment
  • No exclusion will be made on the basis of race, ethnic group or gender.
  • Criteria for inclusion of females and minorities will be those established in the NIH guidelines

Key Trial Info

Start Date :

January 1 2000

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2010

Estimated Enrollment :

184 Patients enrolled

Trial Details

Trial ID

NCT00248625

Start Date

January 1 2000

End Date

October 1 2010

Last Update

July 28 2016

Active Locations (20)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (20 locations)

1

University of California, San Francisco

San Francisco, California, United States, 94143

2

University of Colorado, Denver Children's Hospital

Denver, Colorado, United States, 80218

3

Emory University, Children's Healthcare of Atlanta

Atlanta, Georgia, United States, 30322

4

Children's Memorial Hospital

Chicago, Illinois, United States, 60614